Last week we were joined by Riley Doyle, CEO of Desktop Genetics, and Dr Abel Ureta-Vidal, CEO of Eagle Genomics, for our latest member webinar examining the impact of bioinformatics on drug discovery.

The recent flood of data from genome sequences and functional genomics has given rise to the field of bioinformatics, which combines elements of biology and computer science. Hearing from companies at the heart of bioinformatics, watch the webinar below to find out more about the latest developments in the field and how it can help accelerate drug discovery.

Do you have a video you would like the sector to see? Contact us.